Breast Cancer Symposium

For complete Symposium information and to register, click here.

Faculty Roster
D. Craig Allred, MD Washington University School of Medicine	Cary Kaufman, MD Bellingham Breast Center
Joel Aronowitz, MD Cedars-Sinai Medical Center, Los Angeles	Seema Khan, MD Northwestern University, Evanston
Douglas Arthur, MD Virginia Commonwealth University	Krystyna Kiel, MD Memorial Health Medical Center, Savannah
Harry D. Bear MD, PhD Virginia Commonwealth University	Jean Lynn, OCN, MPH, RN National Cancer Institute, Bethesda
Leonard Berlin, MD Rush North Shore Medical Center, Skokie	Shahla Masood, MD University of Florida, Jacksonville
Aman U. Buzdar, MD M.D. Anderson Cancer Center, Houston	Ellen Mendelson, MD Lynn Sage Comprehensive Breast Center, Chicago
Robert Carlson, MD Stanford University	Olufunmilayo Olopade, MD University of Chicago
Anees Chagpar, MD University of Louisville	Marie Overgaard, MD Aarhus University Hospital, Denmark
Andrea Cheville, MD Mayo Clinic, Rochester	Steve Parker, MD Englewood, Colorado
Stephen A. Feig, MD University of California, Irvine	Sandhya Pruthi, MD Mayo Clinic, Rochester
Charles Geyer, Jr., MD NSABP, Pittsburgh	Barbara Rabinowitz, PhD Meridian Health, Brick
Wendy Harpham, MD Dallas, TX	Wendy Rubinstein, MD, PhD Northwestern University, Evanston
David Hetzel, MD Hope Women’s Cancer Center, Asheville	Ann D. Thor, MD University of Colorado, Aurora
Dennis Holmes, MD University of Southern California	D. Lawrence Wickerham, MD NSABP, Pittsburgh
Clifford Hudis, MD Memorial Sloan-Kettering Cancer Center	David Winchester, MD NAPBC, Evanston
Alison Estabrook, MD St. Luke's & Roosevelt Hospitals, New York	Jo Anne Zujewski, MD National Cancer Institute

Program at a Glance
Thursday, April 2
7:15 – 8:15 am	Exhibit Hall Breakfast
8:15 – 9:00 am	Welcome & Clinical Trials Updates
9:00 – 9:30 am	2009 American Society of Breast Disease Pathfinder Lecture by Steve Parker, MD
9:30 – 11:00 am	High Risk Lesions: Update on Management and Treatment Strategies
11:00 – 11:30 am	Exhibit Hall Break
11:30 am – 1:00 pm	Identification of the High-Risk Patient and Risk-Reduction Strategies
1:00 – 2:00 pm	Luncheon
2:00 – 2:30 pm	Oral Presentations Selected by Abstract Review Committee
2:30 – 4:00 pm	Breast Imaging Modalities: Screening and Diagnostic Use
4:00 – 5:15 pm	Interdisciplinary Tumor Board
5:15 – 6:30 pm	Poster Exhibits & Reception
Friday, April 3
7:15 – 8:00 am	Exhibit Hall Breakfast
8:00 – 8:45 am	The Breast Journal Awards – 2008 Presentations
8:45 – 10:00 am	Breast Cancer Survivorship in 2009
10:00 – 10:20 am	Exhibit Hall Break
10:20 am – 12:15 pm	Treating Local-Regional Failures and IBTR
12:15 – 1:15 pm	Exhibit Hall Luncheon
1:15 - 1:45 pm	2009 American Society of Breast Disease Pathfinder Lecture by Marie Overgaard, MD
1:45 – 2:45 pm	Preparing for Quality Indicators and New National Initiatives
2:45 – 3:15 pm	Exhibit Hall Break
3:15 – 4:30 pm	Minimally Invasive Surgery in an Interdisciplinary Setting
4:30 – 5:15 pm	Oral Presentations Selected by Abstract Review Committee
5:15 – 6:30 pm	Poster Exhibits & Reception
Saturday, April 4
7:30 – 8:30 am	Breakfast
8:30 – 9:00 am	ASBD Annual Business Meeting
9:00 – 10:30 am	Challenges in Neoadjuvant and Adjuvant Therapies
10:30 – noon	Risk Management for Breast Specialists

Learning Objectives After attending the Symposium, participants should be able to: A. Define current options for evaluating and managing atypical hyperplasia B. Describe contemporary issues in treatment of lobular carcinoma in situ C. Identify appropriate risk assessment tools for management of women at high risk for breast cancer D. Recommend genetic testing for management of BRCA 1 and BRCA 2 carriers E. Distinguish appropriate uses of neoadjuvant therapies for early stage breast cancer F. Explain the role of lifestyle modification and chemoprevention as appropriate risk-reduction strategies G. Compare uses of multiple breast-imaging modalities including digital mammography, whole breast ultrasound, breast MRI, thermography, and molecular breast imaging for cancer screening and diagnosis H. Address psychosocial components in management of breast cancer patients and family care I. Consider the implications of long-term management and surveillance on patient quality of life J. Describe issues in managing recurrence of breast cancer K. Consider appropriate uses, based on current clinical trial data, of adjuvant therapies for advanced stage and metastatic breast cancer L. Understand the role of primary care physicians and other healthcare professionals in multidisciplinary management of breast disease M. Discuss approaches to management of local-regional failures, including ipsilateral tumor recurrence N. Describe the differences among multiple national breast cancer quality assurance measures and their implications for practice O. Explain basic principles in oncoplastic surgery and current approaches to breast-conserving surgery in early stage breast cancer P. Participate actively in tumor board case discussions involving risk assessment, screening, benign breast disease management, hormone therapy, uses and candidates for systemic therapy, preoperative therapies, and adjuvant therapies in early stage disease, and use of novel targeted agents Accreditation Statement Beth Israel Medical Center and St Luke’s-Roosevelt Hospital Center are accredited by the Accreditation Council on Continuing Medical Education to sponsor continuing medical education for physicians and take responsibility for the content, quality and scientific integrity of this CME activity. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of St. Luke's and Roosevelt Hospitals and The American Society of Breast Disease. St. Luke's and Roosevelt Hospital is accredited by the ACCME to provide continuing medical education for physicians.” St. Luke’s and Roosevelt Hospitals designates this educational activity for a maximum of 18.25 AMA PRA Category 1 Credits^TM. Each physician should only claim those hours of credit that were actually spent in the educational activity. Policy on Faculty and Provider Disclosure It is the policy of Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center that faculty and sponsors disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. Detailed disclosure information will be made available in the course handout materials. Headquarters Hotel: The Drake Hotel: A Chicago Icon Whether traveling to Chicago for business or pleasure, The Drake Hotel combines tradition with elegance in its 535 rooms, including 74 luxurious suites. Hotel facilities include a well-equipped Fitness Center, a fully staffed Business Center, and a number of arcade level specialty shops. The Drake is also within minutes of many Chicago sporting facilities, including biking, tennis, and beach volleyball. The Drake Hotel is the perfect Chicago venue for meetings and events. Click here to book your room at The Drake Hotel early and secure the special Symposium discounted rate of $239 per night plus applicable taxes. This rate is available on a first-come, first-served basis until March 6, 2009. Plan to join us at the ASBD’s 33rd Annual Symposium – April 2 to 4, 2009, at The Drake Hotel, Chicago, Illinois.